HPV-test, Cervical Cancer and Follow-up

Brief Summary: The investigators have planned this project to evaluate the follow-up program after surgery due to cervical cancer and to explore the possibilities for different tests of Human Papilloma Virus (HPV) in contributing to the customization of the follow-up program.

Purpose:

The investigators effort is to provide the background for an evidence-based update of the follow-up program after surgery due to cervical cancer with the purpose of early diagnosis of recurrence affecting quality of life for as few women as possible.

Recruitment & Eligibility

Inclusion Criteria

Exclusion Criteria

Arm && Interventions

Group	Intervention	Description
Human Papilloma Virus test	Human Papilloma Virus test from the vaginal vault	Patients treated with surgery alone for uterine cervical neoplasms attending surveillance at Dept. of Obstetrics and Gynecology, Oncogynecological unit, Aarhus University Hospital from 01.01.14 From 01.01.15 patients will be recruited from Oncogynecologic units at Aalborg University Hospital and Rigshospitalet. Recruitment of patients from these institutions has not been successful and has been closed. It is expected due to political decisions that the cervical cancer patients from the uptake area of Aalborg University Hospital will be treated at Aarhus University Hospital and they will then be eligible for the study

Primary Outcome Measures

Name	Time	Method
Prevalence of HPV Genotypes in Vagina (Type 16, 18 and Other)	2 years

Secondary Outcome Measures

Name	Time	Method
HPV Clearance From Vagina in Between the Two Planned Follow-up Visits.	2 years

Receive instant email notifications about changes in this clinical trial

Receive instant email notifications about changes in this clinical trial